|
Threat to Horse
Welfare - Equine Voice Needs to be Heard
|
THE support of the
equestrian community is urgently being called upon to help fight far-reaching
proposals to radically change the way veterinary medicines are sold.
As the campaign to
fight European Commission legislation is stepped up
additional support is being sought from the equestrian world in making
its concerns known about the changes.
This is the plea put
out from the Animal Health Alliance (AHA) formed last year to specially
challenge the proposals.
The changes, if approved
would mean all medicines for equines would be obtainable only under prescription.
This would include
not only essential medicines such as horse wormers, (classified as PML)
but also certain over the counter products (so called GSL's) such as some
sweet itch treatments and insecticidal shampoos.
Under the current
system these items are either freely available or as in the case of wormers
are available only from registered outlets when sold by suitably qualified
individuals.
The British Equestrian
Trade Association, (BETA) working as part of the Animal Health Alliance,
has been lobbying against these changes and the Alliance has now submitted
an amendment to Brussels which, if accepted, would allow the UK to continue
to offer medicines in a way similar to the existing system.
Claire Williams, Chief
Executive and Secretary of BETA explains: "We first brought this
to the attention of the Equestrian Industry in October and many did contact
their MP and MEP with their concerns. We are concerned however that people
haven't grasped the seriousness of the potential effects on both horses
directly and the equestrian industry in general."
"If the legislation
goes ahead horse owners would lose the convenience of being able to buy
their wormers and other routinely used medicinal products from their local
retail saddler and as well be faced with the real possibility of increased
prices as competition declines.
"That this would
inevitably be to the detriment of equine welfare as the frequency of treatment
declines is an unavoidable result of the legislation if successfully passed,"
continued Ms Williams.
As well as concerns
over welfare issues and consumer rights the proposals will have a major
impact on the whole equestrian industry. Many retailers and agricultural
merchants are reliant on the turnover and foot-traffic that horse wormers
and other medicines create.
More than 3,000 jobs
could be jeopardised and over 600 retail saddles and 1,000 agricultural
merchants could be affected by the changes.
Currently the proposals
are being considered in Brussels and it is vital that the AHA amendment
be supported as the legislation moves forward.
Claire Williams concludes:
"It is now vital that the equestrian industry and horse owners themselves
make their support of the status-quo clear to both MP's and MEP's and
highlight the negative effects the proposed changes would have on them,
their horses and their livelihoods.
"The United Kingdom
already has a safe and secure system in place for the supply of equine
medicines and little benefit can be seen in changing what is already a
proven and effective distribution structure. Instead it would impose a
degree of over-restriction which could result in illegal trading and a
reduction in competition and choice."
|